Document Type
Article
Publication Date
2022
Keywords
cerebral ischemia, drug treatment, neurogenesis, stem cells, subventricular zone, brain repair
Digital Object Identifier (DOI)
https://doi.org/10.1177/0963689717721230
Abstract
Stroke induces not only cell death but also neurorepair. De novo neurogenesis has been found in the subventricular zone of the adult mammalian brain days after stroke. Most of these newly generated cells die shortly after the insult. Recent studies have shown that pharmacological manipulation can improve the survival of endogenous neuroprogenitor cells and neural regeneration in stroke rats. As these drugs target the endogenous reparative processes that occur days after stroke, they may provide a prolonged window for stroke therapy. Here, we discuss endogenous neurogenesis-enhancing drugs and review the general status of stroke therapeutics in evaluating the field of pharmacotherapy for stroke.
Rights Information
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Was this content written or created while at USF?
Yes
Citation / Publisher Attribution
Cell Transplantation, v. 26, issue 9, p. 1596-1600
Scholar Commons Citation
Wu, Kuo-Jen; Yu, Seongjin; Lee, Jea-Young; Hoffer, Barry; and Wang, Yun, "Improving Neurorepair in Stroke Brain Through Endogenous Neurogenesis-Enhancing Drugs" (2022). Neurosurgery and Brain Repair Faculty Publications. 45.
https://digitalcommons.usf.edu/nbr_facpub/45
